A case of MALT lymphoma coexisting with diffuse large B-cell lymphoma arising in the submaxillary gland
-
- ICHIMURA Norihisa
- Department of Oral and Maxillofacial Surgery, Nagoya University Graduate School of Medicine
-
- YAMAMOTO Noriyuki
- Department of Oral and Maxillofacial Surgery, Nagoya University Graduate School of Medicine
-
- NISHIKAWA Masaya
- Department of Oral and Maxillofacial Surgery, Nagoya University Graduate School of Medicine
-
- YAMAGUCHI Satoshi
- Department of Oral and Maxillofacial Surgery, Nagoya University Graduate School of Medicine
-
- KANO Fumiya
- Department of Oral and Maxillofacial Surgery, Nagoya University Graduate School of Medicine
-
- HIBI Hideharu
- Department of Oral and Maxillofacial Surgery, Nagoya University Graduate School of Medicine
Bibliographic Information
- Other Title
-
- 顎下腺に発生したびまん性大細胞型B細胞リンパ腫を含むMALTリンパ腫の1例
- ガクカセン ニ ハッセイ シタ ビマンセイ ダイ サイボウガタ B サイボウ リンパシュ オ フクム MALT リンパシュ ノ 1レイ
Search this article
Description
<p>Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue type, referred to as mucosa-associated lymphoid tissue (MALT) lymphoma, arises as a low-grade B cell lymphoma associated with chronic inflammation. This disease is relatively rare and accounts for 0.3 percent of all malignant lymphomas. In this article, we report a case of MALT lymphoma coexisting with diffuse large B-cell lymphoma (DLBCL) arising in the submaxillary gland along with a literature review. A 67-year-old woman was referred to our hospital because of indolent right submandibular swelling. Palpable 30 × 25 mm mass was observed on the right submandible. Computed tomography (CT) showed a well-defined oval radiopaque mass measuring approximately 30 × 30 mm. We performed submaxillary gland resection with the patient under anesthesia for a suspected submaxillary gland tumor. A diagnosis of MALT lymphoma coexisting with DLBCL was made on the basis of the histopathological examination and immunohistochemical staining. As additional treatment, 3 cycles of rituximab with CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisone) (R-CHOP) therapy were given after radiotherapy (36 Gy/20 fr) in accordance with the NCCN Guidelines. Currently, the patient is doing well with no recurrence.</p>
Journal
-
- Japanese Journal of Oral and Maxillofacial Surgery
-
Japanese Journal of Oral and Maxillofacial Surgery 64 (8), 470-474, 2018-08-20
Japanese Society of Oral and Maxillofacial Surgeons
- Tweet
Details 詳細情報について
-
- CRID
- 1390282763059796352
-
- NII Article ID
- 130007499848
-
- NII Book ID
- AN00189163
-
- ISSN
- 21861579
- 00215163
-
- NDL BIB ID
- 029222829
-
- Text Lang
- ja
-
- Data Source
-
- JaLC
- NDL Search
- Crossref
- CiNii Articles
- KAKEN
- OpenAIRE
-
- Abstract License Flag
- Disallowed